![In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity | Drug Metabolism & Disposition In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/44/10/1682/F5.large.jpg)
In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity | Drug Metabolism & Disposition
![Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial - The Lancet Oncology Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/73d3fa1f-af78-4bbd-99ed-e59fc5ee48ef/gr1_lrg.jpg)
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial - The Lancet Oncology
![Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517320300533-gr2.jpg)
Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate - ScienceDirect
![New Developments in the Treatment of Castration-Resistant Prostate Cancer in: Journal of the National Comprehensive Cancer Network Volume 12 Issue 5S (2014) New Developments in the Treatment of Castration-Resistant Prostate Cancer in: Journal of the National Comprehensive Cancer Network Volume 12 Issue 5S (2014)](https://jnccn.org/view/journals/jnccn/12/5S/0773tbl01.jpeg)
New Developments in the Treatment of Castration-Resistant Prostate Cancer in: Journal of the National Comprehensive Cancer Network Volume 12 Issue 5S (2014)
![Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study - European Urology Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/15798f53-534a-4bd6-804b-e1eab1564be7/gr1_lrg.jpg)